These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 36233074
1. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide. Cámara-Sánchez P, Díaz-Riascos ZV, García-Aranda N, Gener P, Seras-Franzoso J, Giani-Alonso M, Royo M, Vázquez E, Schwartz S, Abasolo I. Int J Mol Sci; 2022 Oct 04; 23(19):. PubMed ID: 36233074 [Abstract] [Full Text] [Related]
4. Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel. Zhao D, Hu C, Fu Q, Lv H. Eur J Pharm Sci; 2021 Dec 01; 167():105992. PubMed ID: 34517104 [Abstract] [Full Text] [Related]
7. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer. Ring A, Kaur P, Lang JE. BMC Cancer; 2020 Nov 10; 20(1):1076. PubMed ID: 33167919 [Abstract] [Full Text] [Related]
10. BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer. De Santis F, Romero-Cordoba SL, Castagnoli L, Volpari T, Faraci S, Fucà G, Tagliabue E, De Braud F, Pupa SM, Di Nicola M. Cell Oncol (Dordr); 2022 Apr 10; 45(2):257-274. PubMed ID: 35357654 [Abstract] [Full Text] [Related]
12. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells. Chu J, Li Y, Fan X, Ma J, Li J, Lu G, Zhang Y, Huang Y, Li W, Huang X, Fu Z, Yin Y, Yuan H. Cell Physiol Biochem; 2018 Apr 10; 48(2):593-604. PubMed ID: 30021199 [Abstract] [Full Text] [Related]
13. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis. Li Y, Xiao Y, Lin HP, Reichel D, Bae Y, Lee EY, Jiang Y, Huang X, Yang C, Wang Z. Biomaterials; 2019 Jan 10; 188():160-172. PubMed ID: 30352320 [Abstract] [Full Text] [Related]
16. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. Sulaiman A, McGarry S, Lam KM, El-Sahli S, Chambers J, Kaczmarek S, Li L, Addison C, Dimitroulakos J, Arnaout A, Nessim C, Yao Z, Ji G, Song H, Liu S, Xie Y, Gadde S, Li X, Wang L. Cell Death Dis; 2018 Jul 26; 9(8):815. PubMed ID: 30050079 [Abstract] [Full Text] [Related]
20. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR. Kim S, Park JM, Park S, Jung E, Ko D, Park M, Seo J, Nam KD, Kang YK, Lee K, Farrand L, Kim YJ, Kim JY, Seo JH. J Exp Clin Cancer Res; 2023 Nov 04; 42(1):292. PubMed ID: 37924112 [Abstract] [Full Text] [Related] Page: [Next] [New Search]